Comment on “EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation”

• by Alessandra Tedeschi, Raul Cordoba, Alessandra Ferrajoli, George Follows, Anna Maria Frustaci, Anne Sophie Michallet, Talha Munir, Susan O'Brien, John F. Seymour, Tait Shanafelt, Clemens Martin Wendtner, Pier Luigi Zinzani, Stephan Stilgenbauer

• October 13, 2026

CRISPR-Based Delivery System Generates CAR T Cells In Vivo

A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models

• October 13, 2026

• 3 min

EQUIPOISE: EQUivalence In Prostate cancer treatment: surgery Or radiotherapy? An Intention-to-treat Survival analysis from real-world Evidence

• by Gustavo A. Viani, Ana Carolina Hamamura, Caio Viani Arruda, Carlos E. Cardoso, Helio A. Salmon, Gustavo O. Amaral

• October 15, 2026

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min